OLIG2 and glioblastoma: Analysis showed that more than half of the GBM samples (38 out of 61) demonstrated coexistence of presumed edge-like (Olig2+) and core-like (CD109+) cells (Supplementary Fig. 1f), indicating that edge and core signature may be relevant to all subtypes of GBM.